National audienceINTRODUCTION: Pulmonary arterial hypertension (PAH) is a severe complication of systemic sclerosis and detecting PAH efficiently remains challenging. The DETECT study has offered in 2013 a composite screening tool for PAH. The objective of our study was to compare the indication of right heart catheterisation (RHC) as suggested by the DETECT algorithm with the decisions of a multidisciplinary team. METHODS: This prospective monocentric non-interventional study consecutively included systemic sclerosis patients when data required to apply DETECT algorithm were available. We evaluate the number of RHC as requested by this algorithm and confronted it with the indications of RHC suggested by a multidisciplinary group blinded fo...
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclero...
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclero...
There is evidence that early screening for pulmonary arterial hypertension (PAH) in systemic scleros...
National audienceINTRODUCTION: Pulmonary arterial hypertension (PAH) is a severe complication of sys...
OBJECTIVE: Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death in s...
Objective: Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death in s...
Contains fulltext : 137979.pdf (publisher's version ) (Open Access)OBJECTIVE: Earl...
Abstract Background Pulmonary arterial hypertension (PAH) is one of the most relevant causes of deat...
Screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improves outcomes. T...
Background: to compare three existing screening algorithms of pulmonary arterial hypertension (PAH) ...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
Background: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosi...
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclero...
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclero...
There is evidence that early screening for pulmonary arterial hypertension (PAH) in systemic scleros...
National audienceINTRODUCTION: Pulmonary arterial hypertension (PAH) is a severe complication of sys...
OBJECTIVE: Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death in s...
Objective: Earlier detection of pulmonary arterial hypertension (PAH), a leading cause of death in s...
Contains fulltext : 137979.pdf (publisher's version ) (Open Access)OBJECTIVE: Earl...
Abstract Background Pulmonary arterial hypertension (PAH) is one of the most relevant causes of deat...
Screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improves outcomes. T...
Background: to compare three existing screening algorithms of pulmonary arterial hypertension (PAH) ...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
International audienceBackground: to compare three existing screening algorithms of pulmonary arteri...
Background: Pulmonary arterial hypertension (PAH) is a major cause of mortality in systemic sclerosi...
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclero...
Pulmonary arterial hypertension (PAH) is one of the most relevant causes of death in systemic sclero...
There is evidence that early screening for pulmonary arterial hypertension (PAH) in systemic scleros...